Publikationsdatenbank

Pharmacotherapy of canine atopic dermatitis:
current state and new trends (2020)

Art

Zeitschriftenartikel / wissenschaftlicher Beitrag

Autor

Bäumer, Wolfgang (WE 14)

Quelle

Veteriner Fakültesi dergisi

Bandzählung: 67

Heftzählung: 1

Seiten: 107 – 111

ISSN: 1308-2817

Sprache

Englisch

Verweise

URL (Volltext): http://vetjournal.ankara.edu.tr/tr/issue/48774/644485

DOI: 10.33988/auvfd.644485

Kontakt

Institut für Pharmakologie und Toxikologie

Koserstr. 20
14195 Berlin
+49 30 838 53221
pharmakologie@vetmed.fu-berlin.de

Abstract / Zusammenfassung

This review offers a concise overview of current treatment options for canine atopic dermatitis and provide an outline of two promising new treatment options (phosphodiesterase 4 and histamine H4 receptor inhibitors). Glucocorticoids have been one of the first successful treatment options and are still part of the treatment regime. Ciclosporin was introduced more than 15 years ago and is also a main pharmacological treatment option. In 2013, the Janus kinase inhibitor oclacitinib was introduced as a first in class, which is then followed by the anti-canine IL-31 antibody lokivetmab in 2016. Thus, exciting new treatment options have found their way into clinical practice. Apart from these substance classes, antihistamines, essential fatty acids and lipid substitution will be discussed as add-on treatments.